Chinese to English/English to Chinese interpreter/translator in finance and cancer therapy

Working languages:

English to Chinese
Chinese to English

Fei Tang
Connect you to the rest of the world

Shenzhen, Guangdong, China

Local time: 11:03 CST (GMT+8)

Native in: Chinese

Send email

Feedback from
clients and colleagues
on Willingness to Work Again

4 positive reviews

(2 unidentified)

Your feedback

Rate service provider

1 following

What Fei Tang is working on

May 27, 2021 (posted via ProZ.com): Working on translation project for skincare product website now, 15K+ words ...more »

Total word count: 0

Freelance translator and/or interpreter

This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.

This person is not affiliated with any business or Blue Board record at ProZ.com.

Software localization, Subtitling, Interpreting, Translation, Editing/proofreading, Voiceover (dubbing), Native speaker conversation

Specializes in:
Finance (general)	Investment / Securities
Medical: Pharmaceuticals	Medical: Health Care
Medical (general)	Business/Commerce (general)
Economics	Internet, e-Commerce
Advertising / Public Relations	Marketing / Market Research

English to Chinese - Standard rate: 0.10 USD per word / 40 USD per hour / 0.60 USD per audio/video minute
Chinese to English - Standard rate: 0.10 USD per character / 40 USD per hour / 0.60 USD per audio/video minute

PayPal

Sample translations submitted: 2

English to Chinese: 花旗私行投资市场分析 General field: Bus/Financial Detailed field: Investment / Securities
Source text - English Germs of Steel As the flow of information becomes an ever-greater flood, we must stand back in wonder at how investors might adapt. Is it possible that markets react differently to economic challenges than they have in the past? Such conjecture can be dangerous: “This Time It’s Different,” stand as infamous last words. Yet at no other time in the past could one attempt to track each and every case of a viral epidemic, plotted on a global map of 8 billion human beings (see figures 1-2). Will we in the future plot this for mortality, accidents and illnesses of all sorts? 2 Looking back, most investors would also not have had a quantification of past viral epidemics to pattern their real time investment decisions as they do now (see figure 3). History shows temporary dips in asset prices with a subsequent rebound. Has this pattern stopped investors from panic selling in the current case? What then can we expect for a rebound when such a minimal equity price dip has occurred? The “novel coronavirus” or COVID-19 has and will have real economic disruption effects. Yet as discussed in last month’s Quadrant, these effects are led by efforts to shield the public from potential contagion, and are not a permanent loss of output. This led us to reduce allocations to the markets that had not fallen substantially while raising allocations for markets most impacted. With China and Hong Kong equity markets weak for various reasons prior to the virus impact, subsequent returns even in the past two weeks have been strong (see figure 4) In considering what the post crisis rebound period will look like, economic conditions prior to the virus impact are worth noting. In January, global economic data had improved more than we expected for so early in the year (see fig 6). However, as noted last month, certain equity markets seem to not only price-in the likely recovery, but also an uninterrupted recovery. This makes us concerned that merely temporary distortions to the path of the world economy can now lead to greater share price volatility. This may be most true for US equities, which have outperformed non-US equities by a stunning 12.3 percentage points over the past year (see figures 6-7). While this had us reduce the extent of our overweight in US shares last month, the continued “safe haven” flows into US stocks and bonds from global investors may further assist US dollar assets (see figures 8-9). How long these will last is significantly linked to the path of the coronavirus, which is itself guesswork. Of course, there is some risk that the virus spreads away from China itself. While mortality numbers will surely rise, the mere two deaths reported thus far outside mainland China appears consistent with a containable, regional crisis. Thus, it should be pointed out that equity markets are perhaps not the only overly bullish asset class. As figures 10-11 show, both “low risk” and higher-risk fixed income markets have rallied again this year. As yields for investors have fallen, the cost of capital for borrowers has too. Folding in the impact of low yields and credit risk premia, even the US stock market does not seem absurdly mispriced. This is, of course, if US stock and bond investors don’t demand very much return in the future. As figure 12 shows, current prices and yields are consistent with 4%-5% trend (10-year average) US equity returns before inflation. As figure 7 showed, this also comes with significant volatility.	Translation - Chinese 钢铁上的病菌-新型冠状病毒新冠疫情新闻铺天盖地，各类信息不断涌入，此时我们更应避免当局者迷，而是理智地思考市场投资者会怎样反应。市场是否有可能打破以往先例，在危机事件后走出不一样的行情？仅凭猜测有害无益，“这一次果然与之前都不一样，”不过是市场输家的“遗言”。确确实实，过去并没有人能够日度跟踪每一次病毒疫情演绎，制作出覆盖全球80亿人口的疫情形势图表（见图1-2）。那么将来是否有可能以图表形式来覆盖全球人口，跟踪各种疫情，疾病以及意外造成的死亡呢？今时不同往日（见图3），大多数过往投资者并没有历史病毒疫情的数据记录，也就无法根据过往趋势作出当下投资决策。历史先例显示资产价格受疫情影响短暂下挫之后都会迎来回弹。但面对如今的新冠疫情，历史走势是否阻止了危机下的恐慌抛售呢？对于股市估值受疫情影响较小的市场，后续反弹我们又应该抱有怎样的期望？ “新型冠状病毒（COVID-19）已经并且还将对经济造成实质性影响。然而，在上一月象限报告已经有所提及，这些负面影响是限制公众出行的疾控措施引起，并不会对生产造成长远的打击。因此，对于股市受此次疫情影响并不明显的股票市场，我们减少了配置，相应地也对受到病毒危机深度打击的市场进行增配。新冠疫情爆发之前，中国和香港的股票市场已经由于各种原因本就相对低估，不提疫情结束之后长期回弹空间，仅仅在过去两周，股市估值的修复已经相当亮眼。（见图4）若要评估新冠疫情之后市场会如何反弹，则有必要参考病毒危机爆发之前的经济状况。今年1月份，全球经济数据企稳回升，改善幅度远超预期（见图6）。然而，我们在上个月就已经观察到某些市场的定价似乎不仅反映了经济的企稳，甚至还先行一步，预期此次复苏将会持续稳健，如果后市经济恢复过程中出现一些短暂的反复，股市则很有可能因此出现过度波动。上述现象在美国股市尤为突出。过去一年，美国股市大幅跑赢非美股市场，超出12.3个百分点，令人惊讶（见图表6-7）。因此，上个月我们相应的削减了美股持仓。然而，随着全球寻找“避险资产”资金的持续流入，美股与美债资产也势必会持续走高（见图8-9），而这一现象的持续时间也与新冠疫情的进展息息相关，但新冠疫情何时结束，本身也非常难以预测。当然，病毒走出中国蔓延开来的可能性仍然存在。虽然新冠死亡率必然会上升，但目前为止中国以外只报道了2例死亡，表明新冠疫情作为地区性危机事件，目前仍然可控。因此，我们需要认识到不仅仅股票市场存在超涨现象。从图10-11可以看出，“低风险”与“高收益”的固定收益市场估值在今年以来再度双双上扬。不仅是债券收益率下行，资金成本也逐渐降低。考虑目前利率之低和信用风险溢价，美股市场定价似乎也并未超常理过度偏离。当然，站在现在的点位，投资者对美股和美债的后市的投资回报期望也就不能太高。如图12所示，当前美债的价格与收益率带来的回报已经与美股考虑通货膨胀前年度平均4-5%（10年平均）趋于一致。当然，历史并非一帆风顺，图7已经告诉我们平滑回报曲线下隐藏的是巨幅波动。
Chinese to English: 乳腺癌患者病例报告 Breast cancer patient medical records General field: Medical Detailed field: Medical: Health Care
Source text - Chinese 患者于湖南省华容县人民医院行左乳根治术。病理切片诊断为：1.（左侧乳腺）浸润性导管癌；2.（左侧腋窝）淋巴结4/14见癌转移。术后应用紫杉醇联合顺铂化疗一周期，拒绝继续治疗，辅助放疗1程。后服用三苯氧胺2年自行停服。患者于湖南省华容县人民医院CT胸部+上腹部平扫检查，影像诊断：1.左乳Ca术后并胸膜及多发骨转移、右侧第5、7和左侧第3、4、9肋病理性骨折；2.左侧少量胸腔积液；3.主动脉及冠状动脉粥样硬化；4.左肾囊肿可能；5.胸腰椎骨质增生。	Translation - English The patient underwent radical mastectomy of the left breast at Huarong Remin Hospital in Hunan province. Pathological section diagnosis: 1. (Left breast) invasive ductal carcinoma. 2. (Left armpits) LN 4/14 cancer involvement seen. Received 1 cycle of chemotherapy (Paclitaxel+Cisplatin), refused to continue the treatment. Received 1 cycle of adjuvant radiotherapy. Then took tamoxifen for 2 years and stopped herself. The patient underwent CT chest +epigastric scans at Huarong Remin Hospital, and the result was: 1. Left breast Ca Post-surgery with pleural and multiple bone metastases, pathological fracture at the right 5th, 7th and left 3rd, 4th, 9th ribs; 2. Slight left thoracic effusion; 3. Atherosclerosis of aorta and coronary arteries; 4. Possible left renal cysts; 5. Hyperostosis of T spine and L spine.

New! Video portfolio:

Master's degree - University of Leeds

Years of experience: 11. Registered at ProZ.com: Feb 2021.

N/A

English to Chinese ( University of Leeds, verified)
Chinese to English ( University of Leeds, verified)

N/A

Adobe Acrobat, memoQ, MemSource Cloud, Microsoft Excel, Microsoft Word, XTM

Chinese (DOCX), English (PDF)

Fei Tang endorses ProZ.com's Professional Guidelines.

Meet new translation company clients
Meet new end/direct clients
Network with other language professionals
Get help with terminology and resources
Learn more about translation / improve my skills
Learn more about interpreting / improve my skills
Learn more about additional services I can provide my clients
Learn more about the business side of freelancing
Help or teach others with what I have learned over the years
Improve my productivity

Bio

I’m a professionally trained translator and interpreter from the University of Leeds, and I’ve been working as a linguist professional since 2011 by delivering translation and interpretation between Chinese and English for clients from all over the world.

As a current member of the American Translators Association, Chartered Institute of Linguists, and the ProZ Certified Pro Network, I work in various modes, including simultaneous, consecutive and remote interpreting, as well as translating, proofreading, and transcribing. I had 3 years of in-house work experience at a medical company and a joint-stock bank, so, medical and finance fields are my strong suits.

I’ve found that clients and agencies would usually struggle to find professional translators and interpreters who can stay on top of both the cultural subtleties as well as specific knowledge of certain fields when delivering their services.

I spent one year studying in the UK for my interpreting and translating degree. So, for the understanding of cultural differences, checked! Besides, I have more than 6 years of work experience in different companies across different industries, such as financial markets, automobiles, and medical treatment. So, regarding the expertise of those areas, checked.

I can assure you the best quality possible and help you gain peace of mind whatever your demands are when it comes to looking for reliable language services.

Some recent projects I've been working on:

Interpreting:

08/04/2021-09/04-2021 USA Translators The 2021 Global Leadership Conference is ‘GLCx Momentum’ SI-Zoom

08/04/2021 Ping An Bank Real Structured Deposit Business Kick-off Meeting On-site

13/04/2021 Ping An Bank KYZ platform introduction session On-site+Zoom

21/04/2021 Adhoc translations Chr. Hansen corporate branding survey Zoom/Google Meet CI

28/04/2021 Adhoc translations Chr. Hansen corporate branding survey Zoom/Google Meet CI

30/4/2021 Ping An Bank Study on China CGB term premia Zoom/SI

30/4/2021 Ping An Bank CICC analysis sharing on Chinese Bond Market Zoom/Onsite SI

07/05/2021 Ping An Bank Financial markets business quarterly performance review Zoom/Onsite SI

Translation:

19/04/2021	PAB	Macroeconomy analysis weekly report	545	Financial
		Citi bank‘s exit of retail banking in 13 markets including China	480	Financial
		Structured deposit business weekly report	667	Banking
20/04/2021	PAB	Hong Kong Branch Q1 bond portfolio report	438	Investment
21/04/2021	PAB	KYZ model on detecting financial fraud	2380	Financial
22/04/2021	PAB	Investors' questions summary on PAB's annual report roadshow	7880	Investment
05/2021	PAB	JET localization	566	Software
	PAB	Bank AC account investment arrangement	688	Investment
	PAB	Snowball options hedging's opportunities and challenges	3668	Investment and securities
15/05-19/05/2021	THG Fluently	Look Fantastic Website Products	5288	Cosmetics and Beauty Devices
	PAB	Cash management products issued by banks and AMCs and its comparison with money fund products	4421	Investment and securities
20/05/2021	Verasci	The Columbia – Suicide Severity Rating Scale （editing）	4-hour	Clinical trial
25/05/2021	Lingvohouse	BMF marketing content translation（creative）	521	Marketing

Keywords: Chinese, English, finance, medical, cancer treatment, investment, stocks, securities

Profile last updated
Jun 10, 2021

More translators and interpreters: English to Chinese - Chinese to English More language pairs

Your current localization setting

Select a language

You have native languages that can be verified

Your current localization setting

Select a language